China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Short Interest Up 48.3% in July

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC - Get Free Report) saw a significant increase in short interest in July. As of July 31st, there was short interest totaling 72,800 shares, anincreaseof48.3% from the July 15th total of 49,100 shares. Currently,0.1% of the shares of the company are sold short. Based on an average trading volume of 568,100 shares, the short-interest ratio is currently 0.1 days. Based on an average trading volume of 568,100 shares, the short-interest ratio is currently 0.1 days. Currently,0.1% of the shares of the company are sold short.

Wall Street Analyst Weigh In

Separately, Wall Street Zen raised China SXT Pharmaceuticals from a "sell" rating to a "hold" rating in a report on Saturday, August 2nd.

China SXT Pharmaceuticals Price Performance

Shares of China SXT Pharmaceuticals stock remained flat at $1.57 during trading hours on Friday. The stock had a trading volume of 17,398 shares, compared to its average volume of 40,649. China SXT Pharmaceuticals has a 52-week low of $0.95 and a 52-week high of $7.84. The business has a 50 day moving average price of $1.68 and a two-hundred day moving average price of $2.24. The company has a debt-to-equity ratio of 0.01, a current ratio of 3.54 and a quick ratio of 3.40.

China SXT Pharmaceuticals Company Profile

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.